Patent ID: 7485730

Claim:
Tricyclic pyrazole derivatives of formula (I) having affinity for the cannabinoidergic CB1 and/or CB2 receptors: wherein: A represents (CH 2 ) t —, wherein: t is equal to 1; B is thiophene, substituted with a number of substituents from 1 to 2, said substituents being equal to or different from each other and selected from the following: halogen, C 1 -C 7 alkyl, C 1 -C 7 alkylthio, C 1 -C 7 alkoxy, C 1 -C 7 haloalkyl, C 1 -C 7 haloalkoxy, cyano, nitro, amino, N-alkylamino, N,N-dialkylamino, isothiocyanate, phenyl, cycloalkyl, saturated or unsaturated heterocycle, or heteroaryl; R is aryl, arylalkyl or arylalkenyl, not substituted or having from one to five substituents, equal to or different from each other, selected from halogen, C 1 -C 7 alkyl, C 1 -C 7 alkylthio, C 1 -C 7 alkoxy, C 1 -C 7 haloalkyl, C 1 -C 7 haloalkoxy, cyano, nitro, amino, N-alkylamino, N,N-dialkylamino, saturated or unsaturated heterocycle, or phenyl; R′ is a group selected from the following: an amidic substituent of formula —C(O)—NH-T′, T′ being selected from: a C 3 -C 15 cycloalkyl not substituted or substituted with one or more C 1 -C 7 alkyl chains, said chains being from one to four for C 5 -C 15 cycloalkyls, being from one to three for the C 4 cycloalkyl, and being from one to two for the C 3 cycloalkyl, said alkyl groups being equal to or different from each other; or a group NR 1 R 2 , wherein R 1 and R 2 together with the nitrogen atom to which they are linked form a saturated heterocycle from 5 to 10 carbon atoms, and pharmaceutically acceptable salts of said derivatives of formula (I).